Jennison Associates
BHVN icon

Jennison Associates’s Biohaven BHVN Stock Holding History

Jennison Associates’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49,457
Closed -$742K – 588
2025
Q3 		$742K Buy
+49,457
New +$720K ﹤0.01% 499
2025
Q2 		– Sell
-18,741
Closed -$451K – 583
2025
Q1 		$451K Sell
18,741
-78,791
-81% -$2.78M ﹤0.01% 560
2024
Q4 		$3.64M Buy
+97,532
New +$4.55M ﹤0.01% 429
2024
Q2 		– Sell
-265,819
Closed -$14.5M – 576
2024
Q1 		$14.5M Sell
265,819
-572
-0.2% -$28.3K 0.01% 369
2023
Q4 		$11.4M Buy
+266,391
New +$8.28M 0.01% 376

Other funds holding BHVN

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates's BHVN Position: Q4 2025 in Review

Jennison Associates sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 49,457 shares — an estimated $742K sold.

Jennison Associates first reported a position in BHVN in Q4 2023 and held it in 5 quarters. The position peaked at $14.5M in Q1 2024. 273 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • Jennison Associates reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
  • Jennison Associates sold 49,457 Biohaven shares in Q4 2025, an estimated $742K.
  • Jennison Associates first reported a position in Biohaven in Q4 2023 and held it in 5 quarters.
  • Jennison Associates's Biohaven position peaked at $14.5M in Q1 2024.
  • 273 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Jennison Associates's 13F filing for Q4 2025, filed 30 Jan 2026.